As of December 23, health care providers, health plans, and health care clearinghouses (covered entities) and their business associates (collectively, regulated entities) must comply with new reproductive health care privacy...more
12/20/2024
/ Administrative Procedure Act ,
Covered Entities ,
Department of Health and Human Services (HHS) ,
Enforcement ,
Final Rules ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
HIPAA Privacy Rule ,
Loper Bright Enterprises v Raimondo ,
OCR ,
PHI ,
Popular ,
Reproductive Healthcare Issues ,
SCOTUS ,
Statutory Interpretation ,
Texas ,
Trump Administration
On April 26, the US Department of Health and Human Services Office for Civil Rights (OCR) published a Final Rule that adds protections under the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule...more
5/29/2024
/ Attestation Requirements ,
Compliance ,
Covered Entities ,
Data Collection ,
Disclosure Requirements ,
Dobbs v. Jackson Women’s Health Organization ,
Final Rules ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
HIPAA Privacy Rule ,
Investigations ,
Notice Requirements ,
OCR ,
PHI ,
Popular ,
Privacy Laws ,
Reproductive Healthcare Issues ,
SCOTUS
On January 30, a federal jury found six people guilty of federal civil rights offenses arising from their participation in a blockade of a reproductive health care clinic in Mount Juliet, Tennessee. The jury’s verdict is...more
In this installment of our post-Dobbs risk assessment series for hospitals and academic medical centers, we consider the ongoing impact of Dobbs v. Jackson Women’s Health Organization on delivery of clinical services beyond...more
In the landmark case of Dobbs v. Jackson Women’s Health Organization, the US Supreme Court overturned its prior rulings in Roe v. Wade and Planned Parenthood of Southeastern Pennsylvania v. Casey, which had recognized a...more
As those in the reproductive health space scramble to keep up with the ever-changing landscape of mifepristone (Mifeprex) access, it seems that every party must have their say.
The last three months have seen updates from...more
With the approval of the modified mifepristone Risk Evaluation and Mitigation Strategy (REMS), it has been a momentous few weeks in the reproductive health legal space.
Modification to the REMS for Mifepristone...more
Since the US Supreme Court ruled in Dobbs v. Jackson Women’s Health Organization (Dobbs) in June 2022, the impact of the Court’s decision continues to ripple across the health care delivery system. In this multi-part series,...more
12/9/2022
/ Abortion ,
Centers for Medicare & Medicaid Services (CMS) ,
Dobbs v. Jackson Women’s Health Organization ,
EMTALA ,
Environmental Social & Governance (ESG) ,
Hospitals ,
Planned Parenthood of Southeastern Pennsylvania v Casey ,
Reproductive Healthcare Issues ,
Risk Assessment ,
Roe v Wade ,
SCOTUS